Salivary lysozyme
Biomarker1 paper1 finding
- Humans1
Associations
1Cardiovascular mortality
upin humans1HR 2.53
1 study
Cardiovascular mortality
upin humans1HR 2.53
Salivary lysozyme raises the risk of cardiovascular mortality in humans (HR 2.53, 95% CL 1.38 to 4.64).
Humansadjusting for age, sex, smoking status, hypertension, diabetes, dyslipidemia, and educationsaliva18.8 yn = 471
Salivary Lysozymes, Anti-inflammatory Cardiac Medications, and Cardiovascular Mortality · JDR clinical and translational research · 11 Sep 2026
Latest
1JDR Clinical and Translational ResearchHumans